Principia Biopharma, Inc. is a company in the U.S. stock market and it is a holding in 44 U.S.-traded ETFs. PRNB has around 2.5M shares in the U.S. ETF market. The largest ETF holder of PRNB is the SPDR S&P Biotech ETF (XBI), with approximately 707.75K shares. Investors may also find of interest that the ETF with the largest allocation to PRNB stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 2.08%. On average, U.S. ETFs allocate 0.22% of PRNB to their portfolios.
Additionally, PRNB is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PRNB as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 50.24%.